ECM
DCPH

ExodusPoint Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

ExodusPoint Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-160,690
Closed -$2.53M – 2101
2024
Q1 		$2.53M Buy
160,690
+43,758
+37% +$674K 0.02% 612
2023
Q4 		$1.89M Sell
116,932
-218,953
-65% -$2.79M 0.01% 597
2023
Q3 		$4.27M Sell
335,885
-204,431
-38% -$2.82M 0.04% 413
2023
Q2 		$7.61M Buy
540,316
+105,646
+24% +$1.51M 0.06% 312
2023
Q1 		$6.72M Sell
434,670
-144,984
-25% -$2.42M 0.06% 412
2022
Q4 		$9.5M Buy
579,654
+270,685
+88% +$4.4M 0.14% 183
2022
Q3 		$5.72M Sell
308,969
-51,046
-14% -$801K 0.07% 360
2022
Q2 		$4.73M Buy
360,015
+82,860
+30% +$915K 0.06% 428
2022
Q1 		$2.57M Buy
+277,155
New +$2.36M 0.03% 660
2021
Q1 		– Sell
-13,608
Closed -$777K – 2708
2020
Q4 		$777K Buy
+13,608
New +$807K 0.01% 992

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

ExodusPoint Capital Management's DCPH Position: Q2 2024 in Review

ExodusPoint Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 160,690 shares — an estimated $2.53M sold.

ExodusPoint Capital Management first reported a position in DCPH in Q4 2020 and held it in 10 quarters. The position peaked at $9.5M in Q4 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • ExodusPoint Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 160,690 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $2.53M.
  • ExodusPoint Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • ExodusPoint Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $9.5M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.